| 10.71 -0.02 (-0.19%) | 05-03 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 12.53 | 1-year : | 14.64 |
| Resists | First : | 10.73 | Second : | 12.53 |
| Pivot price | 10.7  |
|||
| Supports | First : | 10.67 | Second : | 10.64 |
| MAs | MA(5) : | 10.71 |
MA(20) : | 10.7 |
| MA(100) : | 10.6 |
MA(250) : | 10.44 |
|
| MACD | MACD : | 0  |
Signal : | 0 |
| %K %D | K(14,3) : | 83 |
D(3) : | 87.9 |
| RSI | RSI(14): 58.7 |
|||
| 52-week | High : | 11.15 | Low : | 10.13 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ BLAC ] has closed below upper band by 36.6%. Bollinger Bands are 38.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 10.73 - 10.8 | 10.8 - 10.85 |
| Low: | 10.55 - 10.64 | 10.64 - 10.7 |
| Close: | 10.6 - 10.72 | 10.72 - 10.82 |
Bellevue Life Sciences Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company intends to acquire companies in the healthcare industry. Bellevue Life Sciences Acquisition Corp. was founded in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.
Sat, 27 Apr 2024
Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC) Sees Significant Increase in Short Interest - MarketBeat
Sat, 27 Apr 2024
(BLAC) Trading Report - Stock Traders Daily
Fri, 26 Apr 2024
Bellevue Life Sciences Acquisition Files Proxy on 6-Month Extension to Work on OSR Deal | DealFlow's SPAC News - DealFlow's SPAC News
Tue, 23 Apr 2024
OSR Holdings and SillaJen have entered into a Memorandum of Understanding to collaboratively pursue the ... - PR Newswire
Wed, 17 Apr 2024
Bellevue Life Sciences Acquisition Pursues 6-Month Extension | DealFlow's SPAC News - DealFlow's SPAC News
Tue, 16 Apr 2024
Abrdn Global Infrastructure Income Fund (NYSE:ASGI) Short Interest Update - Defense World
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Shell Companies
|
|
| Shares Out | 6 (M) |
| Shares Float | 6 (M) |
| Held by Insiders | 37.3 (%) |
| Held by Institutions | 56.5 (%) |
| Shares Short | 2 (K) |
| Shares Short P.Month | 1 (K) |
| EPS | 0.05 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.28 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -1.7 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -1 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 214.19 |
| PEG Ratio | 0 |
| Price to Book value | -39.67 |
| Price to Sales | 0 |
| Price to Cash Flow | -111.42 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|